Abatacept for Patients With Inflammatory Arthritis Associated With Sjögren's Syndrome: an Open-Label Phase II Study

Clinical trial NCT02027298 · WITHDRAWN

Trial details

NCT number: NCT02027298
Sponsor: The Cleveland Clinic
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Primary Sjogren's Syndrome Secondary Sjogren's Syndrome Inflammatory Arthritis Rheumatoid Arthritis

Start date: 2013-11-01
Primary completion: 2014-10-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.